哪个预后模型最好预测脊髓转移患者的不良预后? 8个评分系统的比较分析
Se-Jun Park1, Jin-Sung Park1, Dong-Ho Kang1
1Department of Orthopedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
World neurosurgery
|October 16, 2024
概括
在评估脊髓转移的预后评分系统时,这项研究发现大多数预后预测能力较低,预后不佳. 骨瘤学研究小组 (SORG) 诺图显示,预测6个月生存时间的准确性中等.
科学领域:
- 在瘤学瘤学.
- 医学统计 医学统计
- 预测模型的预测建模
背景情况:
- 准确的预后对于管理脊髓转移至关重要.
- 现有的评分系统在预测不良预后 (<6个月生存期) 的有效性需要进一步调查.
研究的目的:
- 为了比较八个已建立的脊髓转移预测评分系统的预测性能.
- 评估这些系统在预测6个月和1个月生存时间方面的准确性.
主要方法:
- 对8种预后评分系统的比较分析 (托米塔,修改后的Tokuhashi,修改后的Bauer,雷德斯,瘤脊髓预后指数,雷伊,新英格兰脊髓转移得分,SORG名谱).
- 使用曲线下的面积 (AUC) 评估预测性能的接收器操作特征 (ROC) 曲线分析.
- 后勤回归用于识别与6个月生存相关的因素.
主要成果:
- 骨瘤学研究小组 (SORG) 号码表显示了预测6个月生存率的最佳表现 (AUC:0.664),尽管具有较低的判别力.
- 对于6个月生存的重要因素包括原发性癌症类型,手术前的弗兰克尔级,白细胞计数,白蛋白水平和化疗状态.
- 对于1个月的生存期,SORG nomogram (AUC:0.750) 和修改后的Tokuhashi评分 (AUC:0.667) 显示出显著性,但具有中度至低的辨别力.
结论:
- 大多数当前的评分系统在预测脊髓转移的不良预后方面表现出有限的区分能力.
- 在SORG nomogram提供适度预测能力为6个月的生存期.
- 未来的预后模型应该整合治疗,生物标志物和瘤生物学方面的进步,以提高准确性.
更多相关视频
相关概念视频
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:20Comparing the Survival Analysis of Two or More Groups
156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
01:24Kaplan-Meier Approach
103
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
103